Phio Pharmaceuticals Corp. is developing therapeutics for cancer using INTASYL technology.
1 report, 1 independent
Updated Jul 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Phio Pharmaceuticals Corp. is developing therapeutics for cancer using INTASYL technology.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Phio Pharmaceuticals Corp., a U.S. manufacturer, provides drug substance development services.Sub-event
Phio Pharmaceuticals Corp. announced development of cancer therapeutics using INTASYL technology.1 source
Keep exploring
The entities involved
-
Cancer
government organization in Paris, France
Nothing else this week.
Coverage
Newest first; wire copies grouped- NewsfilePhio Pharmaceuticals Announces Pathology Results for Four of Five Patients in Fourth Cohort Complete Pathologic Response in patient with cutaneous squamous cell carcinoma Partial Response in Stage 4